Literature DB >> 22187359

Clinical and radiological findings in macroprolactinemia.

Serhat Isik1, Dilek Berker, Yasemin Ates Tutuncu, Ufuk Ozuguz, Ferhat Gokay, Gonul Erden, Hatice Nursun Ozcan, Ferit Kerim Kucukler, Yusuf Aydin, Serdar Guler.   

Abstract

Hyperprolactinemia is the most common abnormality of the hypothalamic-pituitary axis. The aim of this study was to investigate the clinical and radiological features of patients with macroprolactinemia. The study population consisted of patients with elevated serum prolactin (PRL) concentrations who presented to our Endocrinology outpatient clinic. Detection of macroprolactin (macroPRL) was performed using the polyethylene glycol precipitation method. Patients in which macroPRL made up more than 60% of total PRL levels were stratified into the macroPRL group, while the remaining patients were placed in the monomeric prolactin (monoPRL) group. A total of 337 patients were enrolled with a mean age of 33.8 ± 10.8 (16-66) years and a male/female ratio of 29/308. Eighty-eight of the patients (26.1%) had an elevated macroPRL level. The mean age in the monoPRL group was higher than in the macroPRL group (35.0 ± 10.1 vs. 30.7 ± 9.8, P = 0.016). The mean PRL levels (ng/ml) in the macroPRL and monoPRL groups were similar (168.0 ± 347.0 vs. 238.8 ± 584.9, P = 0.239). Frequency of amenorrhea, infertility, irregular menses, gynecomastia, and erectile dysfunction were also similar in both groups. More patients in the macroPRL group were asymptomatic compared to the monoPRL group (30.2 vs. 12.0%, P = 0.006). Compared to the macroPRL group, the monoPRL group had a higher frequency of galactorrhea (39.2 vs. 57.1%, P = 0.04) and abnormal magnetic resonance imaging findings (65.3 vs. 81.1%, P = 0.02). Elevated macroPRL levels should be considered a pathological biochemical variant of hyperprolactinemia that may present with any of the conventional symptoms and radiological findings generally associated with elevated PRL levels.

Entities:  

Mesh:

Year:  2011        PMID: 22187359     DOI: 10.1007/s12020-011-9576-9

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.633


  28 in total

1.  Gross variability in the detection of prolactin in sera containing big big prolactin (macroprolactin) by commercial immunoassays.

Authors:  Thomas P Smith; Abdulwahab M Suliman; Michael N Fahie-Wilson; T Joseph McKenna
Journal:  J Clin Endocrinol Metab       Date:  2002-12       Impact factor: 5.958

2.  Ten-year clinical follow-up of a cohort of 51 patients with macroprolactinemia establishes it as a benign variant.

Authors:  I R Wallace; N Satti; C H Courtney; H Leslie; P M Bell; S J Hunter; D R McCance; B Sheridan; A B Atkinson
Journal:  J Clin Endocrinol Metab       Date:  2010-04-28       Impact factor: 5.958

3.  The impact on clinical practice of routine screening for macroprolactin.

Authors:  J Gibney; T P Smith; T J McKenna
Journal:  J Clin Endocrinol Metab       Date:  2005-04-05       Impact factor: 5.958

4.  Pituitary imaging is indicated for the evaluation of hyperprolactinemia.

Authors:  Aykut Bayrak; Peyman Saadat; Eliran Mor; Lisa Chong; Richard J Paulson; Rebecca Z Sokol
Journal:  Fertil Steril       Date:  2005-07       Impact factor: 7.329

5.  [Detection of asymptomatic prolactinoma by a mass screening program].

Authors:  K Ichihara; K Miyai
Journal:  Rinsho Byori       Date:  1990-06

6.  Further evidence that big,big prolactin is preferentially secreted in women with hyperprolactinemia and normal ovarian function.

Authors:  F Larrea; C Villanueva; M Carmen Cravioto; A Escorza; O del Real
Journal:  Fertil Steril       Date:  1985-07       Impact factor: 7.329

7.  Correlation of the antibody titers with serum prolactin levels and their clinical course in patients with anti-prolactin autoantibody.

Authors:  N Hattori; K Ikekubo; T Ishihara; K Moridera; M Hino; H Kurahachi
Journal:  Eur J Endocrinol       Date:  1994-05       Impact factor: 6.664

8.  Screening for macroprolactinaemia and pituitary imaging studies.

Authors:  Omar M Hauache; Antonio J Rocha; Antonio C M Maia; Rui M B Maciel; José Gilberto H Vieira
Journal:  Clin Endocrinol (Oxf)       Date:  2002-09       Impact factor: 3.478

9.  Frequency of hyperprolactinaemia due to large molecular weight prolactin (150-170 kD PRL).

Authors:  T Bjøro; L Mørkrid; R Wergeland; A Turter; A Kvistborg; T Sand; P Torjesen
Journal:  Scand J Clin Lab Invest       Date:  1995-04       Impact factor: 1.713

10.  Galactorrhea: a study of 235 cases, including 48 with pituitary tumors.

Authors:  D L Kleinberg; G L Noel; A G Frantz
Journal:  N Engl J Med       Date:  1977-03-17       Impact factor: 91.245

View more
  8 in total

1.  Editorial: is macroprolactinemia just a diagnostic pitfall?

Authors:  Marcello D Bronstein
Journal:  Endocrine       Date:  2012-04       Impact factor: 3.633

2.  Macroprolactinemia in hyperprolactinemic infertile women.

Authors:  Krithika Thirunavakkarasu; Pinaki Dutta; Subbiah Sridhar; Lakhbir Dhaliwal; G R V Prashad; Shalini Gainder; Naresh Sachdeva; Anil Bhansali
Journal:  Endocrine       Date:  2013-03-30       Impact factor: 3.633

Review 3.  Concomitant myasthenia gravis and macroprolactinoma: the immunomodulatory role of prolactin and its potential therapeutic use.

Authors:  S M Harris; H M C Leong; R Chowdhury; C Ellis; John Brennan; I N Scobie
Journal:  Endocrine       Date:  2013-06-08       Impact factor: 3.633

4.  Retrospective Analysis of Cushing's Disease with or without Hyperprolactinemia.

Authors:  Cheng Huan; Chao Lu; Guang-Ming Xu; Xin Qu; Yuan-Ming Qu
Journal:  Int J Endocrinol       Date:  2014-11-23       Impact factor: 3.257

5.  Sexual function and depressive symptoms in young women with elevated macroprolactin content: a pilot study.

Authors:  Robert Krysiak; Agnieszka Drosdzol-Cop; Violetta Skrzypulec-Plinta; Bogusław Okopien
Journal:  Endocrine       Date:  2016-02-22       Impact factor: 3.633

Review 6.  Global Prevalence of Macroprolactinemia among Patients with Hyperprolactinemia: A Systematic Review and Meta-Analysis.

Authors:  Noor Azlin Azraini Che Soh; Najib Majdi Yaacob; Julia Omar; Aniza Mohammed Jelani; Noorazliyana Shafii; Tuan Salwani Tuan Ismail; Wan Norlina Wan Azman; Anis Kausar Ghazali
Journal:  Int J Environ Res Public Health       Date:  2020-11-06       Impact factor: 3.390

7.  Macroprolactinemia in a patient with invasive macroprolactinoma: a case report and minireview.

Authors:  Atanaska Elenkova; Zdravka Abadzhieva; Nikolai Genov; Vladimir Vasilev; Georgi Kirilov; Sabina Zacharieva
Journal:  Case Rep Endocrinol       Date:  2013-01-15

8.  Frequency of Macroprolactinemia in Hyperprolactinemic Women Presenting with Menstrual Irregularities, Galactorrhea, and/or Infertility: Etiology and Clinical Manifestations.

Authors:  Alfredo Leaños-Miranda; Karla Leticia Ramírez-Valenzuela; Inova Campos-Galicia; Rosario Chang-Verdugo; Lizbeth Zarela Chinolla-Arellano
Journal:  Int J Endocrinol       Date:  2013-09-30       Impact factor: 3.257

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.